Emerald Multispecialty PA

Emerald Multispecialty PA was paid $102K by Medicaid between Oct 2020 and May 2023, across 21 billing codes. Its largest line is K1034, Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count — 51% of everything it billed.

33Billing provider infoEMERALD MULTISPECIALTY PA
AKRON, OH 44313

33aNPI1598257503assigned 06/05/2018

33bProvider typeFamily Medicine Physician

28Total paid$102K

24GClaims38,973

24DCodes billed21

24AFirst – last monthOct 2020 – May 2023

Compared with peers

Next to other Family Medicine Physician providers in Ohio

Rank by total paid#235 of 739

Median peer was paid$30K

This provider vs. median3.4×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	1,084	$2K
2021	547	$11K
2022	11,084	$37K
2023	26,258	$52K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
K1034	Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count	51%	26,258	20,643	$52K
M0244	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency	7.0%	47	26	$7K
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	6.8%	4,030	1,202	$7K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	6.7%	3,666	1,197	$7K
M0223	Intravenous injection, bebtelovimab, includes injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency	6.2%	229	106	$6K
99304		4.9%	586	374	$5K
99307		4.7%	1,461	337	$5K
M0248	Intravenous infusion, sotrovimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency	3.4%	31	20	$4K
97597		2.6%	653	399	$3K
99308	Subsequent nursing facility care, per day, straightforward	2.3%	554	292	$2K
99305		<1%	215	112	$928.69
96910		<1%	271	59	$853.38

9 more codes

99336		<1%	235	$803.73
17000		<1%	93	$740.17
99309	Subsequent nursing facility care, per day, low to moderate complexity	<1%	171	$663.27
99335		<1%	99	$320.38
17003		<1%	74	$186.68
99454		<1%	49	$36.18
99457		<1%	74	$19.64
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	152	$1.92
99453		0%	25	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialFENSTERSZAUB, SIMON (OWNER)

Same official

Other billing entities under FENSTERSZAUB, SIMON

Full network →

Provider	Location	Paid
SF Connecticut Medical Services PC	Hamden, CT	$218K
On Call Medical Care PC	West Hempstead, NY	$34K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.